SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-008058
Filing Date
2019-08-13
Accepted
2019-08-13 16:01:56
Documents
72
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q atre-20190630x10q.htm 10-Q 2642909
2 EX-10.6 atre-20190630ex106fa731d.htm EX-10.6 22864
3 EX-10.7 atre-20190630ex107b18892.htm EX-10.7 87349
4 EX-31.1 atre-20190630ex3119aff86.htm EX-31.1 11360
5 EX-31.2 atre-20190630ex3125284cc.htm EX-31.2 12212
6 EX-32 atre-20190630xex32.htm EX-32 7336
7 GRAPHIC atre20190630ex106fa731d001.jpg GRAPHIC 4808
  Complete submission text file 0001558370-19-008058.txt   7414040

Data Files

Seq Description Document Type Size
8 EX-101.INS atre-20190630.xml EX-101.INS 1353899
9 EX-101.SCH atre-20190630.xsd EX-101.SCH 39800
10 EX-101.CAL atre-20190630_cal.xml EX-101.CAL 51515
11 EX-101.DEF atre-20190630_def.xml EX-101.DEF 187361
12 EX-101.LAB atre-20190630_lab.xml EX-101.LAB 352773
13 EX-101.PRE atre-20190630_pre.xml EX-101.PRE 323072
Mailing Address 500 SAGINAW DRIVE, FIRST FLOOR REDWOOD CITY CA 94063
Business Address 500 SAGINAW DRIVE, FIRST FLOOR REDWOOD CITY CA 94063 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38935 | Film No.: 191020565
SIC: 2834 Pharmaceutical Preparations